Knowledge Hub

Cesca Therapeutics Inc. (KOOL) - Product Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2016

Press Release   •   Jan 06, 2017 06:09 EST

Cesca Therapeutics Inc. (Cesca) formerly ThermoGenesis Corp. is a medical equipment company. It researches, develops, and commercializes cell based therapeutics for application in regenerative medicine. Its lead technology platform, SurgWerks is used for the collection, separation, storage and delivery of stem cells from adult tissue sources including cord blood and bone marrow. The companys CellWerks MXP system is an integrated protocol and equipment with disposables for rapid intra-laboratory use under the direction of a licensed physician. It finds application in bone marrow transplantation and cellular purification from cord blood. It also offers AutoXpress and MarrowXpress devices for isolating and concentrating hematopoietic stem cells from cord blood and bone marrow; BioArchive automated cryogenic device and manual bag sets for use in the processing and cryogenic storage of cord blood. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. Cesca is headquartered in Rancho Cordova, California, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

View Report at


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Cesca Therapeutics Inc.

- The report provides pipeline analysis on all pipeline products of thecompany (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Get Sample copy Of This Report @

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Cesca Therapeutics Inc. Company Overview 6

Cesca Therapeutics Inc. Company Snapshot 6

Cesca Therapeutics Inc. Pipeline Products and Clinical Trials Overview 7

Cesca Therapeutics Inc. Pipeline Analysis Overview 8

Business Description 8

Key Facts 9

Cesca Therapeutics Inc. - Major Products and Services 10

Cesca Therapeutics Inc. Clinical Trials by Trial Status 11

Cesca Therapeutics Inc. Pipeline Products Overview 13

CellWerks - ABO Mismatch 13

CellWerks - ABO Mismatch Product Overview 13

CellWerks - Haplo-identical 14

CellWerks - Haplo-identical Product Overview 14

CellWerks BMT 15

CellWerks BMT Product Overview 15

SurgWerks - AVN 16

SurgWerks - AVN Product Overview 16

SurgWerks - Ischemic Stroke 17

SurgWerks - Ischemic Stroke Product Overview 17

SurgWerks - Non-Healing Ulcers 18

SurgWerks - Non-Healing Ulcers Product Overview 18

SurgWerks - Non-Union Fractures 19

SurgWerks - Non-Union Fractures Product Overview 19

SurgWerks - Osteoarthritis 20

SurgWerks - Osteoarthritis Product Overview 20

SurgWerks - SF 21

SurgWerks - SF Product Overview 21

SurgWerks AMI Kit 22

SurgWerks AMI Kit Product Overview 22

SurgWerks AMI Kit Clinical Trial 23

SURGWERKS-CLI Therapy Kit - Intra-arterial 24

SURGWERKS-CLI Therapy Kit - Intra-arterial Product Overview 24

SURGWERKS-CLI Therapy Kit - Intra-arterial Clinical Trial 25

VXP System 26

VXP System Product Overview 26

VXP System Clinical Trial 27

Cesca Therapeutics Inc. - Key Competitors 28

Cesca Therapeutics Inc. - Key Employees 29

Cesca Therapeutics Inc. - Locations And Subsidiaries 31

Head Office 31 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.